EKS-HOS-00245
Eukaryotic Protein Kinase & Protein Phosphatase Database
TagContent
EKPD IDEKS-HOS-00245
Classification
Group/FamilyScoreE-ValueStartEndDomain Length
TK/Abl557.51.9E-167242493252
StatusReviewed
Ensembl ProteinENSP00000323315
UniProt AccessionP00519; A3KFJ3; Q13869; Q13870; Q16133; Q17R61; Q45F09;
Protein NameTyrosine-protein kinase ABL1
Protein Synonyms/Alias Abelson murine leukemia viral oncogene homolog 1; Abelson tyrosine-protein kinase 1; Proto-oncogene c-Abl; p150;
Gene NameABL1
Gene Synonyms/Alias ABL1; ABL, JTK7;
Ensembl Information
Ensembl Gene IDEnsembl Protein IDEnsembl Transcript ID
ENSG00000097007ENSP00000376971ENST00000393293
ENSG00000097007ENSP00000361423ENST00000372348
ENSG00000097007ENSP00000323315ENST00000318560
OrganismHomo sapiens
Functional DescriptionNon-receptor tyrosine-protein kinase that plays a rolein many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage- induced apoptosis. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. ABL1 acts also as a regulator of multiple pathological signaling cascades during infection. Several known tyrosine- phosphorylated microbial proteins have been identified as ABL1 substrates. This is the case of A36R of Vaccinia virus, Tir (translocated intimin receptor) of pathogenic E.coli and possibly Citrobacter, CagA (cytotoxin-associated gene A) of H.pylori, or AnkA (ankyrin repeat-containing protein A) of A.phagocytophilum. Pathogens can highjack ABL1 kinase signaling to reorganize the host actin cytoskeleton for multiple purposes, like facilitating intracellular movement and host cell exit. Finally, functions as its own regulator through autocatalytic activity as well as through phosphorylation of its inhibitor, ABI1.
Protein Length1130
Protein Sequence
(FASTA)
MLEICLKLVG CKSKKGLSSS SSCYLEEALQ RPVASDFEPQ GLSEAARWNS KENLLAGPSE 60
NDPNLFVALY DFVASGDNTL SITKGEKLRV LGYNHNGEWC EAQTKNGQGW VPSNYITPVN 120
SLEKHSWYHG PVSRNAAEYL LSSGINGSFL VRESESSPGQ RSISLRYEGR VYHYRINTAS 180
DGKLYVSSES RFNTLAELVH HHSTVADGLI TTLHYPAPKR NKPTVYGVSP NYDKWEMERT 240
DITMKHKLGG GQYGEVYEGV WKKYSLTVAV KTLKEDTMEV EEFLKEAAVM KEIKHPNLVQ 300
LLGVCTREPP FYIITEFMTY GNLLDYLREC NRQEVNAVVL LYMATQISSA MEYLEKKNFI 360
HRDLAARNCL VGENHLVKVA DFGLSRLMTG DTYTAHAGAK FPIKWTAPES LAYNKFSIKS 420
DVWAFGVLLW EIATYGMSPY PGIDLSQVYE LLEKDYRMER PEGCPEKVYE LMRACWQWNP 480
SDRPSFAEIH QAFETMFQES SISDEVEKEL GKQGVRGAVS TLLQAPELPT KTRTSRRAAE 540
HRDTTDVPEM PHSKGQGESD PLDHEPAVSP LLPRKERGPP EGGLNEDERL LPKDKKTNLF 600
SALIKKKKKT APTPPKRSSS FREMDGQPER RGAGEEEGRD ISNGALAFTP LDTADPAKSP 660
KPSNGAGVPN GALRESGGSG FRSPHLWKKS STLTSSRLAT GEEEGGGSSS KRFLRSCSAS 720
CVPHGAKDTE WRSVTLPRDL QSTGRQFDSS TFGGHKSEKP ALPRKRAGEN RSDQVTRGTV 780
TPPPRLVKKN EEAADEVFKD IMESSPGSSP PNLTPKPLRR QVTVAPASGL PHKEEAGKGS 840
ALGTPAAAEP VTPTSKAGSG APGGTSKGPA EESRVRRHKH SSESPGRDKG KLSRLKPAPP 900
PPPAASAGKA GGKPSQSPSQ EAAGEAVLGA KTKATSLVDA VNSDAAKPSQ PGEGLKKPVL 960
PATPKPQSAK PSGTPISPAP VPSTLPSASS ALAGDQPSST AFIPLISTRV SLRKTRQPPE 1020
RIASGAITKG VVLDSTEALC LAISRNSEQM ASHSAVLEAG KNLYTFCVSY VDSIQQMRNK 1080
FAFREAINKL ENNLRELQIC PATAGSGPAA TQDFSKLLSS VKEISDIVQR 1130
Nucleotide Sequence
(FASTA)
ATGTTGGAGA TCTGCCTGAA GCTGGTGGGC TGCAAATCCA AGAAGGGGCT GTCCTCGTCC 60
TCCAGCTGTT ATCTGGAAGA AGCCCTTCAG CGGCCAGTAG CATCTGACTT TGAGCCTCAG 120
GGTCTGAGTG AAGCCGCTCG TTGGAACTCC AAGGAAAACC TTCTCGCTGG ACCCAGTGAA 180
AATGACCCCA ACCTTTTCGT TGCACTGTAT GATTTTGTGG CCAGTGGAGA TAACACTCTA 240
AGCATAACTA AAGGTGAAAA GCTCCGGGTC TTAGGCTATA ATCACAATGG GGAATGGTGT 300
GAAGCCCAAA CCAAAAATGG CCAAGGCTGG GTCCCAAGCA ACTACATCAC GCCAGTCAAC 360
AGTCTGGAGA AACACTCCTG GTACCATGGG CCTGTGTCCC GCAATGCCGC TGAGTATCTG 420
CTGAGCAGCG GGATCAATGG CAGCTTCTTG GTGCGTGAGA GTGAGAGCAG TCCTGGCCAG 480
AGGTCCATCT CGCTGAGATA CGAAGGGAGG GTGTACCATT ACAGGATCAA CACTGCTTCT 540
GATGGCAAGC TCTACGTCTC CTCCGAGAGC CGCTTCAACA CCCTGGCCGA GTTGGTTCAT 600
CATCATTCAA CGGTGGCCGA CGGGCTCATC ACCACGCTCC ATTATCCAGC CCCAAAGCGC 660
AACAAGCCCA CTGTCTATGG TGTGTCCCCC AACTACGACA AGTGGGAGAT GGAACGCACG 720
GACATCACCA TGAAGCACAA GCTGGGCGGG GGCCAGTACG GGGAGGTGTA CGAGGGCGTG 780
TGGAAGAAAT ACAGCCTGAC GGTGGCCGTG AAGACCTTGA AGGAGGACAC CATGGAGGTG 840
GAAGAGTTCT TGAAAGAAGC TGCAGTCATG AAAGAGATCA AACACCCTAA CCTGGTGCAG 900
CTCCTTGGGG TCTGCACCCG GGAGCCCCCG TTCTATATCA TCACTGAGTT CATGACCTAC 960
GGGAACCTCC TGGACTACCT GAGGGAGTGC AACCGGCAGG AGGTGAACGC CGTGGTGCTG 1020
CTGTACATGG CCACTCAGAT CTCGTCAGCC ATGGAGTACC TGGAGAAGAA AAACTTCATC 1080
CACAGAGATC TTGCTGCCCG AAACTGCCTG GTAGGGGAGA ACCACTTGGT GAAGGTAGCT 1140
GATTTTGGCC TGAGCAGGTT GATGACAGGG GACACCTACA CAGCCCATGC TGGAGCCAAG 1200
TTCCCCATCA AATGGACTGC ACCCGAGAGC CTGGCCTACA ACAAGTTCTC CATCAAGTCC 1260
GACGTCTGGG CATTTGGAGT ATTGCTTTGG GAAATTGCTA CCTATGGCAT GTCCCCTTAC 1320
CCGGGAATTG ACCTGTCCCA GGTGTATGAG CTGCTAGAGA AGGACTACCG CATGGAGCGC 1380
CCAGAAGGCT GCCCAGAGAA GGTCTATGAA CTCATGCGAG CATGTTGGCA GTGGAATCCC 1440
TCTGACCGGC CCTCCTTTGC TGAAATCCAC CAAGCCTTTG AAACAATGTT CCAGGAATCC 1500
AGTATCTCAG ACGAAGTGGA AAAGGAGCTG GGGAAACAAG GCGTCCGTGG GGCTGTGAGT 1560
ACCTTGCTGC AGGCCCCAGA GCTGCCCACC AAGACGAGGA CCTCCAGGAG AGCTGCAGAG 1620
CACAGAGACA CCACTGACGT GCCTGAGATG CCTCACTCCA AGGGCCAGGG AGAGAGCGAT 1680
CCTCTGGACC ATGAGCCTGC CGTGTCTCCA TTGCTCCCTC GAAAAGAGCG AGGTCCCCCG 1740
GAGGGCGGCC TGAATGAAGA TGAGCGCCTT CTCCCCAAAG ACAAAAAGAC CAACTTGTTC 1800
AGCGCCTTGA TCAAGAAGAA GAAGAAGACA GCCCCAACCC CTCCCAAACG CAGCAGCTCC 1860
TTCCGGGAGA TGGACGGCCA GCCGGAGCGC AGAGGGGCCG GCGAGGAAGA GGGCCGAGAC 1920
ATCAGCAACG GGGCACTGGC TTTCACCCCC TTGGACACAG CTGACCCAGC CAAGTCCCCA 1980
AAGCCCAGCA ATGGGGCTGG GGTCCCCAAT GGAGCCCTCC GGGAGTCCGG GGGCTCAGGC 2040
TTCCGGTCTC CCCACCTGTG GAAGAAGTCC AGCACGCTGA CCAGCAGCCG CCTAGCCACC 2100
GGCGAGGAGG AGGGCGGTGG CAGCTCCAGC AAGCGCTTCC TGCGCTCTTG CTCCGCCTCC 2160
TGCGTTCCCC ATGGGGCCAA GGACACGGAG TGGAGGTCAG TCACGCTGCC TCGGGACTTG 2220
CAGTCCACGG GAAGACAGTT TGACTCGTCC ACATTTGGAG GGCACAAAAG TGAGAAGCCG 2280
GCTCTGCCTC GGAAGAGGGC AGGGGAGAAC AGGTCTGACC AGGTGACCCG AGGCACAGTA 2340
ACGCCTCCCC CCAGGCTGGT GAAAAAGAAT GAGGAAGCTG CTGATGAGGT CTTCAAAGAC 2400
ATCATGGAGT CCAGCCCGGG CTCCAGCCCG CCCAACCTGA CTCCAAAACC CCTCCGGCGG 2460
CAGGTCACCG TGGCCCCTGC CTCGGGCCTC CCCCACAAGG AAGAAGCTGG AAAGGGCAGT 2520
GCCTTAGGGA CCCCTGCTGC AGCTGAGCCA GTGACCCCCA CCAGCAAAGC AGGCTCAGGT 2580
GCACCAGGGG GCACCAGCAA GGGCCCCGCC GAGGAGTCCA GAGTGAGGAG GCACAAGCAC 2640
TCCTCTGAGT CGCCAGGGAG GGACAAGGGG AAATTGTCCA GGCTCAAACC TGCCCCGCCG 2700
CCCCCACCAG CAGCCTCTGC AGGGAAGGCT GGAGGAAAGC CCTCGCAGAG CCCGAGCCAG 2760
GAGGCGGCCG GGGAGGCAGT CCTGGGCGCA AAGACAAAAG CCACGAGTCT GGTTGATGCT 2820
GTGAACAGTG ACGCTGCCAA GCCCAGCCAG CCGGGAGAGG GCCTCAAAAA GCCCGTGCTC 2880
CCGGCCACTC CAAAGCCACA GTCCGCCAAG CCGTCGGGGA CCCCCATCAG CCCAGCCCCC 2940
GTTCCCTCCA CGTTGCCATC AGCATCCTCG GCCCTGGCAG GGGACCAGCC GTCTTCCACC 3000
GCCTTCATCC CTCTCATATC AACCCGAGTG TCTCTTCGGA AAACCCGCCA GCCTCCAGAG 3060
CGGATCGCCA GCGGCGCCAT CACCAAGGGC GTGGTCCTGG ACAGCACCGA GGCGCTGTGC 3120
CTCGCCATCT CTAGGAACTC CGAGCAGATG GCCAGCCACA GCGCAGTGCT GGAGGCCGGC 3180
AAAAACCTCT ACACGTTCTG CGTGAGCTAT GTGGATTCCA TCCAGCAAAT GAGGAACAAG 3240
TTTGCCTTCC GAGAGGCCAT CAACAAACTG GAGAATAATC TCCGGGAGCT TCAGATCTGC 3300
CCGGCGACAG CAGGCAGTGG TCCAGCGGCC ACTCAGGACT TCAGCAAGCT CCTCAGTTCG 3360
GTGAAGGAAA TCAGTGACAT AGTGCAGAGG TAG 3393
Domain Profile
S: 1     iimkhklgggqygevyegvwkkysltvavktlkedtmeveeflkeaavmkelkhpnlvql  60
         i+mkhklgggqygevyegvwkkysltvavktlkedtmeveeflkeaavmke+khpnlvql
Q: 242   ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL  301
         89**********************************************************
S: 61    lgvctreppfyiitefmsygnlldylreadreeveavvllymatqissameylekknfih  120
         lgvctreppfyiitefm+ygnlldylre++r+ev+avvllymatqissameylekknfih
Q: 302   LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH  361
         ************************************************************
S: 121   rdlaarnclvgenklvkvadfglsrlmkedtytahagakfpikwtapeslaynkfsiksd  180
         rdlaarnclvgen+lvkvadfglsrlm++dtytahagakfpikwtapeslaynkfsiksd
Q: 362   RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD  421
         ************************************************************
S: 181   vwafgvllweiatygmspypgidlsqvyellekgyrmerpegcppkvyelmracwkwsps  240
         vwafgvllweiatygmspypgidlsqvyellek+yrmerpegcp+kvyelmracw+w+ps
Q: 422   VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPS  481
         ************************************************************
S: 241   drpsfaeihqal  252
         drpsfaeihqa+
Q: 482   DRPSFAEIHQAF  493
         *********986
Domain Sequence
(FASTA)
ITMKHKLGGG QYGEVYEGVW KKYSLTVAVK TLKEDTMEVE EFLKEAAVMK EIKHPNLVQL 60
LGVCTREPPF YIITEFMTYG NLLDYLRECN RQEVNAVVLL YMATQISSAM EYLEKKNFIH 120
RDLAARNCLV GENHLVKVAD FGLSRLMTGD TYTAHAGAKF PIKWTAPESL AYNKFSIKSD 180
VWAFGVLLWE IATYGMSPYP GIDLSQVYEL LEKDYRMERP EGCPEKVYEL MRACWQWNPS 240
DRPSFAEIHQ AF 252
Keyword3D-structure; Acetylation; Alternative splicing; Apoptosis; ATP-binding; Autophagy; Cell adhesion; Chromosomal rearrangement; Complete proteome; Cytoplasm; Cytoskeleton; DNA damage; DNA repair; DNA-binding; Endocytosis; Kinase; Lipoprotein; Magnesium; Manganese; Membrane; Metal-binding; Mitochondrion; Myristate; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome; SH2 domain; SH3 domain; Transferase; Tyrosine-protein kinase; Ubl conjugation.
Sequence SourceEnsembl
Orthology
Ortholog group
Ailuropoda melanoleuca"; ?>Anolis carolinensis"; ?>Bos taurus"; ?>Caenorhabditis elegans"; ?>Callithrix jacchus"; ?>Canis familiaris"; ?>Cavia porcellus"; ?>Ciona intestinalis"; ?>Ciona savignyi"; ?>Danio rerio"; ?>Dasypus novemcinctus"; ?>Drosophila melanogaster"; ?>Equus caballus"; ?>Felis catus"; ?>Gallus gallus"; ?>Gasterosteus aculeatus"; ?>Gorilla gorilla"; ?>Ictidomys tridecemlineatus"; ?>Latimeria chalumnae"; ?>Loxodonta africana"; ?>Macaca mulatta"; ?>Meleagris gallopavo"; ?>Microcebus murinus"; ?>Monodelphis domestica"; ?>Mus musculus"; ?>Mustela putorius furo"; ?>Myotis lucifugus"; ?>Nomascus leucogenys"; ?>Oreochromis niloticus"; ?>Ornithorhynchus anatinus"; ?>Oryctolagus cuniculus"; ?>Oryzias latipes"; ?>Otolemur garnettii"; ?>Pan troglodytes"; ?>Pelodiscus sinensis"; ?>Petromyzon marinus"; ?>Pongo abelii"; ?>Pteropus vampyrus"; ?>Rattus norvegicus"; ?>Sarcophilus harrisii"; ?>Sus scrofa"; ?>Taeniopygia guttata"; ?>Takifugu rubripes"; ?>Tarsius syrichta"; ?>Tetraodon nigroviridis"; ?>Tursiops truncatus"; ?>Xenopus tropicalis"; ?>Xiphophorus maculatus"; ?>
EKS-AIM-00218
EKS-ANC-00228
EKS-BOT-00257
EKS-CAE-00214
EKS-CAJ-00243
EKS-CAF-00245
EKS-CAP-00293
EKS-CII-00141
EKS-CIS-00017
EKS-DAR-00593
EKS-DAN-00005
EKS-DRM-00121
EKS-EQC-00230
EKS-FEC-00244
EKS-GAG-00198
EKS-GAA-00320
EKS-GOG-00256
EKS-ICT-00225
EKS-LAC-00270
EKS-LOA-00268
EKS-MAM-00261
EKS-MEG-00204
EKS-MIM-00012
EKS-MOD-00237
EKS-MUM-00242
EKS-MUP-00256
EKS-MYL-00237
EKS-NOL-00240
EKS-ORN-00335
EKS-ORA-00227
EKS-ORC-00244
EKS-ORL-00286
EKS-OTG-00264
EKS-PAT-00226
EKS-PES-00229
EKS-PEM-00134
EKS-POA-00230
EKS-PTV-00011
EKS-RAN-00271
EKS-SAH-00243
EKS-SUS-00223
EKS-TAG-00253
EKS-TAR-00332
EKS-TAS-00010
EKS-TEN-00297
EKS-TUT-00026
EKS-XET-00314
EKS-XIM-00328
Gene Ontology
GO:0015629; C:actin cytoskeleton
GO:0005829; C:cytosol
GO:0005739; C:mitochondrion
GO:0031965; C:nuclear membrane
GO:0005730; C:nucleolus
GO:0048471; C:perinuclear region of cytoplasm
GO:0003785; F:actin monomer binding
GO:0005524; F:ATP binding
GO:0003677; F:DNA binding
GO:0000287; F:magnesium ion binding
GO:0030145; F:manganese ion binding
GO:0004515; F:nicotinate-nucleotide adenylyltransferase activity
GO:0004715; F:non-membrane spanning protein tyrosine kinase activity
GO:0030036; P:actin cytoskeleton organization
GO:0006914; P:autophagy
GO:0007411; P:axon guidance
GO:0007596; P:blood coagulation
GO:0007155; P:cell adhesion
GO:0006975; P:DNA damage induced protein phosphorylation
GO:0006897; P:endocytosis
GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage response
GO:0006298; P:mismatch repair
GO:0042692; P:muscle cell differentiation
GO:0071901; P:negative regulation of protein serine/threonine kinase activity
GO:0018108; P:peptidyl-tyrosine phosphorylation
GO:0043065; P:positive regulation of apoptotic process
GO:0051149; P:positive regulation of muscle cell differentiation
GO:0051353; P:positive regulation of oxidoreductase activity
GO:2000249; P:regulation of actin cytoskeleton reorganization
GO:0010506; P:regulation of autophagy
GO:0030155; P:regulation of cell adhesion
GO:0051726; P:regulation of cell cycle
GO:2000145; P:regulation of cell motility
GO:0030100; P:regulation of endocytosis
GO:2001020; P:regulation of response to DNA damage stimulus
GO:0000115; P:regulation of transcription involved in S phase of mitotic cell cycle
GO:0042770; P:signal transduction in response to DNA damage
KEGG
hsa:25;
InterPros
IPR015015; F-actin_binding.
IPR011009; Kinase-like_dom.
IPR000719; Prot_kinase_cat_dom.
IPR017441; Protein_kinase_ATP_BS.
IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
IPR000980; SH2.
IPR001452; SH3_domain.
IPR008266; Tyr_kinase_AS.
IPR020635; Tyr_kinase_cat_dom.
Pfam
PF08919; F_actin_bind; 1.
PF07714; Pkinase_Tyr; 1.
PF00017; SH2; 1.
PF00018; SH3_1; 1.
SMARTs
SM00808; FABD; 1.
SM00252; SH2; 1.
SM00326; SH3; 1.
SM00219; TyrKc; 1.
Prosites
PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00109; PROTEIN_KINASE_TYR; 1.
PS50001; SH2; 1.
PS50002; SH3; 1.
Prints
PR00401; SH2DOMAIN.
PR00109; TYRKINASE.
Created Date20-Feb-2013